Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans

European Journal of Clinical Investigation

Volumn 30, Issue 1, 2000, Pages 45-52

  Baldeweg, S E ^a   Golay, A ^b   Natali, A ^c   Balkau, B ^d   Del Prato, S ^e   Coppack, S W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d INSERM   (France)

^e Univ College London Medical School ^*

Author keywords

Hyperinsulinaemic clamp; Lipoprotein; Nonesterified fatty acids; Triglyceride

Indexed keywords

FATTY ACID; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FATTY ACID BLOOD LEVEL; GENDER; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STEADY STATE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0002031490     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00597.x     Document Type: Article

References (49)

1. 1 DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
2. 2 Van Gala L, Vansant G, De Leeuw IH. Syndrome little X. Relationship to atherosclerotic indices in type II diabetes. Diabetologia 1991;34:A60 (Abstract).
3. 3 Balkau B, Charles M-A, Fontbonne A et al. The plurimetabolic syndrome and the Paris Prospective Study. In: Crepaldi G, Tiengo A, Manzato E, editors. Diabetes, Obesity and Hyperlipidaemia: V The Plurimetabolic Syndrome. Amsterdam, London, New York, Tokyo:Excerpta Medica;1993.p.25-30.
4. 4 Zambon S, Solini A, Manzato E. Lipoproteins, hypertension, microalbuminuria, and insulin resistance in type 2 diabetes. In: Crepaldi G, editor. Diabetes, Obesity and Hyperlipidaemia: V The Plurimetabolic Syndrome. Amsterdam, London, New York, Tokyo:Excerpta Medica;1993.p.209-13.
5. 5 Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol-Rev 1995;75:473-86.
6. 6 Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976;12:563-71.
7. 7 Zavaroni I, Dall'Aglio E, Alpi O et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 1985;55:259-63.
8. 8 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
9. 9 Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentration. J Intern Medicine 1992;231:25-30.
10. 10 Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992;82:1-8.
11. 11 Laakso M, Sarlund H, Mykkönen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223-31.
12. 12 Reaven GM. The fourth Musketeer-from Alexander Dumas to Claude Bernard. Diabetologia 1995;38:3-13.
13. 13 Kissebah AH, Adams PW, Wynn V. Inter-relationships between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenetylbiguanide (phenformin). Diabetologia 1974;10:119-30.
14. 14 Nestel PJ. Relationship between FFA flux and TGFA influx in plasma before and during the infusion of insulin. Metabolism 1967;16:1123-32.
15. 15 Mostaza JM, Vega GL, Snell P, Grundy SM. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue. J Intern Med 1998;243:265-74.
16. 16 Golay A, Zech L, Shi M-Z, Chiou Y-A, Reaven GM, Chen YD. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab 1987;65:512-8.
17. 17 Del Prato S, Enzi G, Vigili de Kreutzenberg S et al. Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 1990;33:228-36.
18. 18 Boden G, Chen X, Ruiz J, White J, Rossetti L. Mechanism of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-46.
19. 19 Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 1986;63:481-4.
20. 20 Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherogenesis. Diabetes Care 1991;14:839-55.
21. 21 Willett WC, Manson JE, Stampfer MJ et al. Weight, weight change and coronary heart disease in woman: risk within the 'normal' weight range. J Am Assoc 1995;273:461-5.
22. 22 Ferrannini E, Camastra S, Coppack SW, Fliser D, Golay A, Mitrakou A. Insulin action and non-esterified fatty acids. Proc Nutrition Society 1997;56:753-61.
23. 23 Björntorp P. Fatty acids, hyperinsulinaemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994:166-74.
24. 24 Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin Action and Age. Diabetes 1996;45:947-53.
25. 25 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
26. 26 Levy JC, Atkinson AB, Bell PM, McCance DR, Hadden DR. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 Diabetes mellitus: the 10-year follow-up of the Belfast Diet study. Diabetic Med 1998;15:290-6.
27. 27 DeFronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 1979;28:1095-101.
28. 28 Robert JJ, Cummins JC, Wolfe RR et al. Quantitative aspects of glucose production and metabolism in healthy elderly subjects. Diabetes 1982;31:203-11.
29. 29 Fink RI, Wallace P, Olefsky JM. Effects of aging on glucose-mediated glucose disposal and glucose transport. J Clin Invest 1986;77:2034-41.
30. 30 Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA. Effect of insulin on the distribution and disposal of glucose in man. J Clin Invest 1985;76:367-74.
31. 31 Hume R. Prediction of lean body mass from height and weight. J Clin Pathology 1966;19:389-91.
32. 32 Fulcher GR, Walker M et al. The assessment of insulin action in vivo. In: Alberti KGMM, De Fronzo RA, Keen H, Zimmet P, editors. International Textbook of Diabetes Mellitus. New York:Wiley;1992:513-30.
33. 33 Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994;14: 1940-5.
34. 34 Lithell H, Jacobs I, Vessby JB, Hellsing K, Karlsson J. Decrease of lipoprotein lipase activity in skeletal muscle in man during a short-term carbohydrate-rich dietary regime. With special reference to HDL-cholesterol, apolipoprotein and insulin concentrations. Metabolism 1982;31:994-8.
35. 35 Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb 1991;1:1192-203.
36. 36 Knudesen P, Eriksson J, Lahdenpera S et al. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 1995;38:344-50.
37. 37 Widjaja A, Levy JC, Morris RJ, Frayn KN, Brabant G, Turner RC. Plasma 3-OH butyrate and triglycerides are markers of the state of fat stores that regulate leptin secretion. Diabetes 1998;47:A1639 (Abstract).
38. 38 Ybarra J, Golay A, Peter-Riesch B, Bioletto S, James RW. Lipoprotein postprandial response to a balanced meal in non-insulin dependent diabetic patients before and after improvement of glycaemic control. Nutr Metab Cardiovasc Dis 1998;8:5-11.
39. 39 Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. The Lancet 1963;1:785-9.
40. 40 Roden M, Price TB, Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans. J-Clin-Invest Jun 1996;15:97 (12): 2859-65.
41. 41 Ferrannini E, Barret EJ, Bevilacqua S, DeFronzo RA. Effects of fatty acids on glucose production and utilization in man. J Clin Invest 1983;72:1737-47.
42. 42 Saloranta C, Groop L. Interactions between glucose and NEFA metabolism in man. Diabetes Metab Rev 1996;12:15-36.
43. 43 Girard J. Role of free fatty acids in insulin resistance of subjects with non-insulin-dependent diabetes. Diabetes Metab 1995;21:79-88.
44. 44 Unger RH. Lipotoxicity in the Pathogenesis of obesity-dependent NIDDM. genetic and clinical implications. Diabetes 1995;44:863-70.
45. 45 Fraze E, Donner CC, Swislocki ALM, Chiou Y-A, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985;61:807-11.
46. 46 Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996;90:243-53.
47. 47 Coppack SW. Lawrence Lecture 1995: Mrs Sprat's diabetes: some metabolic insights. Diabetic Med 1996;13:616-24.
48. 48 Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-66.
49. 49 Bruning JC, Michael MD, Winnay JN et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998;2:559-69.